Biotech Investing

Q BioMed 'looking for a significant return for shareholders' – CEO Denis Corin

Biotech Investing

Biotech Investing

Denis Corin, chief executive of Q BioMed Inc. (OTCQB:QBIO) ) tells Proactive’s Andrew Scott their objective is to find innovative, under-valued and under-appreciated biotech assets out in the pharma world and bring them in-house through licensing and option agreements. ”[We’re] agnostic in terms of exit …. as long as there’s a significant return for shareholders”, …

Denis Corin, chief executive of Q BioMed Inc. (OTCQB:QBIO) ) tells Proactive’s Andrew Scott their objective is to find innovative, under-valued and under-appreciated biotech assets out in the pharma world and bring them in-house through licensing and option agreements.
”[We’re] agnostic in terms of exit …. as long as there’s a significant return for shareholders”, Corin says.

Watch Full Interview here

Click here to connect with Q BioMed Inc. (OTCQB:QBIO) to receive an Investor Presentation.

Source: www.proactiveinvestors.com

Biotech Investing

Outlook Reports

Browse Companies

MARKETS

Markets
TSX	22112.46	+37.36
TSXV	584.88	+14.36
DOW	39127.14	-43.10
S&P 500	5211.49	+5.68
NASD	16277.46	+37.01
ASX	7887.90	-9.00

COMMODITIES

Commodities
Gold	2300.32	+20.36
Silver	27.21	+1.06
Copper	4.22	+0.02
Oil	85.59	+0.16
Heating Oil	2.73	0.00
Natural Gas	1.84	0.00